Freebies to cost Sanofi $109 million

Share this article:

Sanofi will pay up to $109 million to settle allegations that it gave healthcare providers free units of its knee injection drug Hyalgan to induce them to prescribe the drug, according to the Department of Justice. The settlement also resolves claims that the company submitted false average sales price reports for Hyalgan that omitted the free units distributed.


Share this article:

More in Products

Nurse technology contest seeks applications

Nurses who want to share the ways technology has led to a better student or patient outcome are invited to enter a contest that touts two $10,000 cash awards.

Accessory for swimming approved for cochlear implants

Accessory for swimming approved for cochlear implants ...

The Food and Drug Administration has approved the Aqua+ accessory, a waterproof, behind-the-ear product for cochlear implant recipients. The accessory allows Cochlear™ Nucleus® 5 and Nucleus 6 Implant recipients2 to ...

Non-Invasive Open Ventilation System approved

Non-Invasive Open Ventilation System approved

Breathe Technologies, which makes the Non-Invasive Open Ventilation (NIOV) System, said the Food and Drug Administration has granted the fifth 510(k) clearance for the product.